• Explore /
  • Poster
  • / <span>Short-length DNA fragments in plasma to predict clinical outcome in unresected glioblastoma patients.</span>

Short-length DNA fragments in plasma to predict clinical outcome in unresected glioblastoma patients.

Abstract Poster

Authors

null

Maxime Fontanilles

INSERM UMR 1245 Brain And Cancer Genomics, Rouen, France

Maxime Fontanilles , Arthur Daban , Ludivine Beaussire , Émilie Lévêque , Isabelle Tennevet , Olivier Langlois , Ovidiu Veresezan , Florent Marguet , Florian Clatot , Frédéric Di Fiore , Nasrin Vasseur

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Biologic Correlates

Clinical Trial Registration Number

NCT02617745

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2025)

DOI

10.1200/JCO.2023.41.16_suppl.2025

Abstract #

2025

Poster Bd #

382

Abstract Disclosures

Similar Posters

First Author: Dorota Goplen

Poster

2020 ASCO Virtual Scientific Program

Phase III TRIDENT trial: Radiation and temozolomide +/- tumor treating fields in newly diagnosed glioblastoma.

Phase III TRIDENT trial: Radiation and temozolomide +/- tumor treating fields in newly diagnosed glioblastoma.

First Author: Wenyin Shi

First Author: Andrew Jehyun Song

First Author: Mitsuaki Shirahata